Medical therapy through the skin is a well-described practice. Transdermal applications of patches containing medicine for treating pain, nausea, heart failure, and dementia are commonplace. All these regimens permit the prolonged transfer of drugs into the body, so there is a continuous amount of the drug in the bloodstream. An alternative option for transdermal therapy is to use a gas, instead of a patch. The use of gas has been less common due to the difficulty in transporting the gas and administering it in a controlled fashion. AirJector•Vet solves those issues and allows veterinarians to offer this therapeutic option in an easy to use, portable and low cost format.
The AirJector•Vet uses pharmacopeia grade medical gases to vaporize warm water into a therapeutic mist that is enclosed around the therapy site in a sealed environment of pure gas. This sealed atmosphere maximizes continuous transfer of gas into the tissue for the full twenty to thirty minute therapy cycle.
AirJector•Vet, as well as the gases and covers used with the device, may be purchased only by licensed veterinarians.
Airjector•Vet & The Power of CO2
Laboratory studies in cells, animals and humans clearly demonstrate that carbon dioxide has many potential mechanisms for treating a variety of diseases.
Transdermal carbon dioxide dramatically increases tissue blood flow and oxygenation. It also decreases concentration of HIF1 alpha and it directly decreases the main biological compound that regulates inflammation (NFkB). And, transdermal carbon dioxide has a powerful role in reducing the reactive oxygen species (ROS) thus ameliorating the ROS activity.
Additional biological benefits of CO2 include:
Increased nitric oxide thus enhancing flow dependent dilation
Increased mitochondrial biogenesis
Promotion of VEGF upregulation
Neovascularization and capillary growth
Activation of myogenesis thus accelerating muscle injury repair over fibrosis
Suppression of the growth of metastic squamous cells and osteosarcoma
Clinical research has shown positive effects of transcutaneous carbon dioxide in treating peripheral vascular disease, exercise endurance, skin grafts, wound healing, muscle disuse, tumorigenesis, and bone fractures. In addition, there is every reason to predict positive effects for laminitis; although, it has not yet been tested.
Airjector•Vet in Practice
The benefits of CO2 therapy, when coupled with the ease of use and affordability of treatments, make equine and canine athletes ideal candidates for transdermal carbon dioxide therapy.
Treatments can be delivered in the hospital, the barn, the paddock or the pasture. No excessive training is necessary. While CO2 must be administered under the supervision of a veterinarian, any member or the staff or even the animal's owner or trainer can deliver the treatments.
Our recommended standard protocol is to treat the condition for twenty minutes every day for five days and then every other day for seven additional treatments. In some cases, such as fractures, soft tissue injuries, slow healing wounds and lesions deep within the limb, additional treatments may be necessary.
The AirJector•Vet device, as well as the gases and covers used with the device, may be purchased only by licensed veterinarians.
Information & Resources
The AIRJECTOR•VET is
Handheld And Easy To Use
Classified As A Low Risk Medical Device In The EU
Administers FDA Approved Medical Gases, Tested To EP Standards
Measurable Results In Minutes
Provides Reliable Revenue With No Capital Investment
Delivered Directly To Symptomatic Areas
A Premium, Durable Device Engineered For Frequent Use
All carbon dioxide sold by us for use with the device is USP Pharmacopeia grade CO2 manufactured in FDA registered medical gas facilities to ensure the highest quality, purity and consistency.